Paragon 28 Executive and Leadership Team

Albert DaCosta, the Chief Executive Officer at Paragon 28, directs the company's overall strategic vision and operational execution. DaCosta guides the development and global distribution of specialized foot and ankle surgical systems, aligning product innovation with market needs. This leadership involves overseeing the expansion of plating systems, precision guide technologies, and orthobiologics, ensuring each contributes to improved patient care and surgeon efficiency. Albert DaCosta drives the company's growth by fostering key relationships with hospitals and distributors, solidifying Paragon 28's position in the medical device sector. The CEO's mandate includes championing the company's mission to provide cutting-edge solutions for complex orthopedic challenges, thereby enhancing the quality of life for individuals experiencing foot and ankle conditions.

James Riegler, the Chief Financial Officer at Paragon 28, manages all financial operations and strategic fiscal planning. Riegler oversees budgeting, forecasting, and financial reporting, ensuring robust financial health and compliance across domestic and international markets. This role is critical for supporting the company's research, development, and distribution of advanced foot and ankle surgical systems. James Riegler works closely with executive leadership to secure funding, optimize resource allocation, and drive profitability, directly impacting the company's ability to innovate and expand its product lines, including plating systems and orthobiologics. The CFO's oversight extends to managing investor relations and ensuring the financial stability necessary for sustained growth in the competitive medical device industry.

Matthew Millard, the Chief Human Resources Officer at Paragon 28, leads all aspects of human capital management and organizational development. Millard is responsible for cultivating a high-performance culture that supports the company's mission of advancing foot and ankle surgical solutions. This involves talent acquisition, employee relations, compensation and benefits, and ensuring compliance with labor laws across all operational regions. Matthew Millard collaborates with executive leadership to align HR strategies with business objectives, fostering an environment conducive to innovation in areas like plating systems and orthobiologics. The CHRO's focus is on attracting and retaining top talent essential for driving the company's growth and maintaining its competitive edge in the medical device manufacturing sector.

Lee Rosenthal, the Vice President, National Accounts at Paragon 28, spearheads the strategic management and expansion of key client relationships within the United States. Rosenthal directs efforts to secure and grow business with major hospitals and ambulatory surgery centers, ensuring their access to Paragon 28's comprehensive portfolio of foot and ankle surgical systems. This involves developing tailored solutions and fostering strong partnerships to drive adoption of innovative products like plating systems and orthobiologics. Lee Rosenthal's leadership is crucial for achieving revenue targets and market penetration, directly supporting the company's distribution network of sales representatives and stocking distributors. The VP's role emphasizes understanding and meeting the evolving needs of national accounts to solidify Paragon 28's market leadership.